Squarepoint
YCBD icon

Squarepoint’s cbdMD YCBD Stock Holding History

Squarepoint’s Portfolio YCBD Stock Details YCBD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-31
Closed -$32K – 3499
2021
Q2 		$32K Buy
+31
New +$37.1K ﹤0.01% 3132
2021
Q1 		– Sell
-371
Closed -$394K – 3693
2020
Q4 		$394K Buy
371
+112
+43% +$102K ﹤0.01% 2000
2020
Q3 		$187K Buy
+259
New +$247K ﹤0.01% 2120

Other funds holding YCBD

AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
LWM
Lionsbridge Wealth Management Jacksonville Beach, Florida $99.5M AUM 25.42% 1-Year Est. Return

Squarepoint's YCBD Position: Q3 2021 in Review

Squarepoint sold out of cbdMD (YCBD) in Q3 2021, closing a stake of 31 shares — an estimated $32K sold.

Squarepoint first reported a position in YCBD in Q3 2020 and held it in 3 quarters. The position peaked at $394K in Q4 2020. 58 funds tracked by Wall St. Rank hold YCBD as of Q3 2021.

  • Squarepoint reported no remaining cbdMD position as of Q3 2021 after selling out during the quarter.
  • Squarepoint sold 31 cbdMD shares in Q3 2021, an estimated $32K.
  • Squarepoint first reported a position in cbdMD in Q3 2020 and held it in 3 quarters.
  • Squarepoint's cbdMD position peaked at $394K in Q4 2020.
  • 58 funds tracked by Wall St. Rank held cbdMD as of Q3 2021.

Based on Squarepoint's 13F filing for Q3 2021, filed 15 Nov 2021.